The US Justice Department called an economist on Wednesday to testify that allowing AT&T to purchase movie and TV production company Time Warner would cost consumers hundreds of millions of dollars, as the government wrapped up efforts to convince a federal judge to halt the proposed deal.
Carl Shapiro, an economics professor at the University of California at Berkeley, said the planned $85.4 billion merger would give AT&T, which owns satellite and streaming television provider DirecTV, leverage to charge more for Time Warner’s Turner family of channels, which includes sports content and CNN.
It would also give AT&T the opportunity to coordinate with Comcast Corp , which owns NBCU, to starve cheaper online video companies of content, he said.
Shapiro is expected to be the government’s last witness as it seeks to show that the proposed merger is illegal under antitrust law because it would raise pay TV costs to consumers. The government filed a lawsuit in November and is asking US District Court Judge Richard Leon to block the deal.
Following Shapiro, AT&T’s lawyers are expected to call their own economist, Dennis Carlton of the University of Chicago.
Shapiro testified that AT&T’s ownership of DirecTV means that it will likely raise rates for content when it negotiates contracts with other cable and satellite companies, and will be more willing to let contracts lapse so DirecTV could win over irritated subscribers when the rival “goes dark.”
Full Content: Variety
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas